Day: March 17, 2026

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host its inaugural R&D Day on Wednesday, April 8, 2026 in New York City. The event will be webcast live from 8:00am to 11:00am EST and will include presentations from Mesoblast’s senior leadership team and from key opinion leaders. The event will include discussions regarding the company’s corporate strategy, successful commercialization of its flagship product Ryoncil®, and its robust multi-billion-dollar pipeline opportunities in inflammatory pain and cardiovascular disease. In addition, the company will unveil new technology that will drive innovation for the next era of cellular medicines. Dr. Silviu Itescu, Chief Executive of Mesoblast, said: ”Our inaugural...

VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (the “Company”) (TSX:SWP) announces that its Board of Directors (the “Board”) has approved the adoption of a Shareholder Rights Plan, pursuant to a Shareholder Rights Plan Agreement entered into with Computershare Investor Services Inc., as Rights Agent, dated and effective March 17, 2026. The Shareholder Rights Plan is similar to modern rights plans adopted by other Canadian public companies. It was not adopted in response to any specific proposal or intention to acquire control of the Company. The Shareholder Rights Plan will provide the Board and shareholders of the Company with adequate time to consider and evaluate proposals and enable the Board to consider alternatives to ensure shareholders receive full and fair value for their...

SAN JOSE, Calif., March 17, 2026 (GLOBE NEWSWIRE) — On Friday, March 13, 2026, the California Public Utilities Commission issued a proposed decision (PD) on the 2024 General Rate Case of California Water Service (2024 California GRC), the largest subsidiary of California Water Service Group (Company or Group, NYSE:CWT). The PD authorizes additional revenues of $92.3 million in 2026 (a rate increase of 11.1%); $50.8 million in 2027 (a rate increase of 5.5%); and $52.4 million in 2028 (a rate increase of 5.4%). The final infrastructure investment budget for 2025 through 2027 was not included in the PD; however, the Company anticipates it will be provided as an attachment to the final decision. Although the PD does not authorize the Company’s request to decouple sales from revenues to promote conservation and lower water rates for...

SAN FRANCISCO, March 17, 2026 (GLOBE NEWSWIRE) — The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced that Ajay Gopal, the company’s Chief Financial Officer, will participate in a fireside chat at the 38th Annual Roth Conference on Monday, March 23. Mr. Gopal is scheduled to present at 3:00pm PT (6:00pm ET). Registration for the live webcast is available on The RealReal’s investor website at https://investor.therealreal.com/. A replay will be available for 90 days following the event. About The RealReal Inc.The RealReal is the world’s largest online marketplace for authenticated, resale luxury goods, trusted by more than 40 million members. Our full-service consignment model—offering virtual appointments, in-home pickup, drop-off, and direct shipping—enables consumers...

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) — Gemini Space Station, Inc. (“Gemini”) (NASDAQ: GEMI), a global crypto and prediction markets platform, today announced an update to the timing of its fourth quarter and full year 2025 earnings conference call. As previously announced, Gemini will release its fourth quarter and full year 2025 financial results at approximately 4:05 pm ET on Thursday, March 19, 2026. Management will now host a conference call on Friday, March 20, 2026 at 8:30 am ET to discuss the results, rather than on March 19, 2026 as previously announced. The event will be webcast live via our investor relations website https://investors.gemini.com/ or via this link. Parties interested in joining via teleconference can register using this link. After registering, you will be provided dial-in details and a unique dial-in...

REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that nine oral and poster presentations highlighting advances across its RAS(ON) inhibitor pipeline will be featured at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22, 2026 in San Diego. The presentations will include new Phase 1 data for zoldonrasib, a RAS(ON) G12D-selective inhibitor, in patients with previously treated KRAS G12D mutant non-small cell lung cancer, which will be featured in a plenary session. The company will also present two Phase 1/2 datasets evaluating daraxonrasib, a RAS(ON) multi-selective inhibitor, in patients with first line metastatic pancreatic...

HOUSTON, March 17, 2026 (GLOBE NEWSWIRE) — NOV Inc. (NYSE: NOV) announced today that Sanjay Chowbey has been appointed to the Company’s Board of Directors (the “Board”), effective March 17, 2026. “We are pleased to welcome Sanjay Chowbey to our board of directors,” said Jose Bayardo, Chairman, President, and Chief Executive Officer. “Sanjay brings a successful track record of leading high-quality global industrial companies and extensive experience driving manufacturing and operational excellence. We are confident that Sanjay’s expertise will help drive additional value for NOV’s shareholders.” Mr. Chowbey has more than 20 years of experience leading global manufacturing and industrial technology businesses, including in his current role as the President and Chief Executive Officer of Kennametal Inc. (NYSE: KMT), a global manufacturer...

SHANGHAI, China, March 17, 2026 (GLOBE NEWSWIRE) — Qfin Holdings, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qfin Holdings” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025 and raised semi-annual dividend. Fourth Quarter 2025 Business HighlightsAs of December 31, 2025, our platform has connected 167 financial institutional partners and 291.3 million consumers*1 with potential credit needs, cumulatively, an increase of 11.5% from 261.2 million a year ago. Cumulative users with approved credit lines*2 were 63.6 million as of December 31, 2025, an increase of 11.8% from 56.9 million as of December 31, 2024. Cumulative borrowers with successful drawdown, including repeat borrowers was 38.9 million as of December...